PM March 13th Options Begin Trading

Philip Morris International (PM) is trading at $178.28 and the article outlines two option strategies: selling a $175 put (bid $3.60) which sets an effective purchase basis of $171.40 and is ~2% out-of-the-money with a 59% chance to expire worthless, yielding 2.06% (17.48% annualized) if it does; and selling a covered call at the $180 strike (bid $5.00) which is ~1% out-of-the-money with a 51% chance to expire worthless, offering a 3.77% total return if called or a 2.80% premium boost (23.83% annualized) if it expires worthless (March 13 expiration referenced). Implied volatilities are 29% for the put and 32% for the call versus a 12-month trailing volatility of 27%, indicating modestly elevated option pricing that income-oriented investors can exploit depending on directional view and willingness to be assigned.

Analysis

Market structure: Short-dated option sellers and income-focused equity holders are the clear beneficiaries—selling the PM Mar‑13 $175 put yields 2.06% over the term (17.5% annualized) while the $180 covered call yields ~3.77% if assigned. Dealers and volatility providers capture spread revenue but option buyers pay a modest premium (IV 29–32% vs realized 27%), signalling a mildly complacent market skewed toward premium harvesting. Cross-asset note: PM is FX‑sensitive (significant non‑USD revenue), so USD strength or a bond‑market risk‑off move could compress EPS and lift implied vol quickly.

Risk assessment: Low‑probability/high‑impact regulatory or excise shocks (EU plain‑packaging, major tax hikes, or an adverse FDA Iqos ruling) could trigger >20% downside in quarters; litigation/regulatory headlines are the primary tail. Time horizons: immediate (days to Mar‑13 expiry — theta decay dominates), short term (next 3–6 months — earnings, FX, regulatory updates), long term (years — secular cigarette decline vs heated‑tobacco adoption and buybacks). Hidden dependencies include currency translation, excise‑tax pass‑through limits, and buyback cadence; catalysts that would flip the trade are FDA/EU rulings, a >2% sustained USD rally, or an unexpected surprise in heated‑tobacco volumes.

Trade implications: Tactical: sell cash‑secured Mar‑13 PM $175 puts at $3.60 only as a way to acquire shares at $171.40 with one contract per $17,500 reserved cash; size at 1–2% portfolio and buy back if stock < $170 or IV > 40%. For holders, write Mar‑13 $180 covered calls at $5.00 to boost yield (cap upside); hedge large positions with a cheap longer‑dated protective put (e.g., Jun $165) if regulatory risk rises. Relative trade: go long PM vs short MO (Altria) on a 6–12 month horizon to express international exposure and stronger buyback/margin profile, exit if spread tightens by >10%.

Contrarian angles: The market is underpricing regulatory tail risk — 59% OTM probability for the $175 put understates the chance of an outsized adverse ruling within 6–12 months. Conversely, IV is only modestly above realized, so aggressive premium selling is only justified with strict stop/size rules; history (prior regulatory scares) shows large intrayear moves but eventual recovery driven by pricing and buybacks. Unintended consequence: if PM rallies on Iqos adoption or buybacks, covered‑call sellers will forgo substantial upside; set alerts to unwind if PM rallies >5% pre‑expiry or IV compresses >8 vol points.

Key Decisions for Investors

• Establish a cash‑secured short position: sell-to-open PM Mar‑13 2026 $175 puts at $3.60 (one contract per $17,500 cash). Limit size to 1–2% of portfolio; close if PM < $170 or IV > 40% (buy to close) to avoid overweighting regulatory tail risk.
• If already long PM, write Mar‑13 2026 $180 covered calls at $5.00 to harvest ~2.8% term premium (3.77% if assigned). Cap allocation to existing long position; buy back calls if PM > $185 pre‑expiry to recapture upside or if IV drops >8 vol points.
• Hedge material exposure: buy one Jun‑2026 PM $165 put (or nearest strike) per 100 shares held if regulatory headlines escalate; be willing to pay up to ~1.5–2.0% of notional for peace‑of‑mind protection over 3–6 months.
• Implement a relative value pair: go long PM / short MO equal‑dollar (ticker MO) 6–12 months to express better international mix and buyback profile. Size to 1–3% net exposure and unwind if MO outperforms by >10% or PM/MO spread tightens beyond historical 1‑yr bands.
• Set tactical monitoring triggers: reduce PM exposure by 50% within 48 hours if (a) FDA/EU issues adverse consumer/tobacco ruling, (b) USD index strengthens >2% vs basket in 7 days, or (c) PM reports heated‑tobacco volume decline >5% QoQ.